Companies / ADO

ANTEOTECH LTD

ASX:ADOPharmaceuticals, Biotechnology & Life Sciences
3.26B shares on issueASX (delayed) · snapshot 11 Sept 20263.56B fully diluted+9.1% if every option and right converts$0.020price · delayed$65.2Mmarket cap · indicative

Today’s holders own 91.6% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Share count grew 32% in 24 months; 3 cash raises in 24 months; runway 4–8 quarters

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway6.0 quarters of funding
Share-count growth (24m)32.0%
Raise cadence (24m)3 cash raises
Options & rights overhang9.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

ANTEOTECH LTD's ordinary share count increased 32.0% from July 2024 to June 2026, reaching 3.26B shares. In the past 24 months, the company undertook 3 capital raises totalling A$8.9M, with the most recent being a A$3.8M placement in January 2026. Approximately 298M new shares could be issued from options and rights, representing 9.1% of the current share count, with the nearest expiry in September 2026. At the June 2026 quarter end, the company held A$10.0M in available cash, sufficient for 6.0 quarters of operations. One proposed securities issue is planned, with an expected date in September 2026.

AI-generated summary of this page's cited filings · updated 8 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
9.1%
Options & rights overhang
0.0%
In-the-money supply
1
Raises · last 12 months
6.0 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 3.26B per ASX (delayed) (snapshot 11 Sept 2026).
2.75B3.00B3.25BDec 24Oct 25Sept 26Cash raise · 21 Jan 20263.26B

Cash runway

6.0 qtrs
More than four quarters of funding at the recent spend rate.
Funds operations to about Dec 2027 at the reported spend rate.
$10.0M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $11.2M cash at quarter end (item 4.6), 7.1 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
13 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
17 July 20263G · unquotedORDINARY FULLY PAID3.26BAppendix 3G
3 June 20262A · quoted issueADO : ORDINARY FULLY PAID3.26BAppendix 2A
1 June 20262A · quoted issueADO : ORDINARY FULLY PAID3.09BAppendix 2A
11 May 20263H · cancellationADO : ORDINARY FULLY PAID2.97BAppendix 3H
9 Feb 20263H · cancellationADO : ORDINARY FULLY PAID2.97BAppendix 3H
Free account
29 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

3 cash raises in the last 24 months · 1 in the last 12 months

every 7.2 monthsaverage gap between raises
7.7 monthssince the most recent
8 Nov 2024 – 21 Jan 2026first to most recent in this window
$3.8M
Placement
21 Jan 2026 COMPLETE
Free account
5 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
8 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

About 33% of the 15% placement capacity left — about 67% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-09-12). The company has also placed under the additional 10% (Listing Rule 7.1A), which is not counted in this figure. Holder-approved issues and any later ratification are not deducted, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
1 pending issue on record — Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Unlocks on a paid plan
See plans

Options & convertible securities

9.1%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
298.0M
Potential new shares
Sept 2026
Nearest expiry
What a price move would switch on
149.0M298.0M$0.020 now0.25× today ($0.005) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.010) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.015) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.020) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.025) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.030) — 0 of the priced supply in the money, 0.0% of shares on issue2× today ($0.040) — 202.3M of the priced supply in the money, 6.2% of shares on issue3× today ($0.060) — 219.7M of the priced supply in the money, 6.7% of shares on issue5× today ($0.100) — 298.0M of the priced supply in the money, 9.1% of shares on issue10× today ($0.200) — 298.0M of the priced supply in the money, 9.1% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.020 today, 0 securities are in the money (0.0% of shares on issue). At double today’s price it is 202.3M (6.2% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
CodeSecurityTypeExercise priceExpiryOn issueSource
ADOAYOptionsPrice-triggered$0.06413 Sept 202673.3MFiling
ADOAAAOptionsPrice-triggered$0.06414 Nov 20265.0MFiling
ADOAZOptionsPrice-triggered$0.04830 Nov 202610.5MFiling
ADOAABOptionsPrice-triggered$0.04826 Nov 20276.9MFiling
ADOAAFOptionsPrice-triggered$0.03531 Jan 2028138.2MFiling
ADOAAEOptionsPrice-triggered$0.03726 Nov 202812.5MFiling
ADOAADOptionsPrice-triggered$0.03719 Aug 202951.6MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account
7 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
1 June 2026Geoff CummingBuy585k——$20k3Y notice
1 June 2026Geoff CummingOther—600k——3Y notice
1 June 2026Geoff CummingSell3.0M——$108k3Y notice
Free account
6 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

8 Sept 2026Resignation of Chief Financial Officer and Company Secretary
7 Sept 2026Next Generation Battery Agreement with Airspeeder
31 Aug 2026Annual Staff Performance Review Process
31 Aug 2026Proposed issue of securities - ADO
30 Aug 2026$PAppendix 4E and Unaudited Financial Statements
26 Aug 2026Updated Securities Trading Policy
23 Aug 2026ADLM 2026 Expands Life Sciences Sales Pipeline
19 Aug 2026$PAnteo S Strategic Collaboration and Sales Agreement Executed
19 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
17 July 2026Notification regarding unquoted securities - ADO
16 July 2026Appointment of CFO and Company Secretary
30 June 2026ADO Completes CLIA Program- Advances Commercial Relationship
29 June 2026$PNew Product- Anteo C - launched and Shipped for Scale Trials
11 June 2026Investor Presentation Gold Coast Investment Showcase
4 June 2026Cleansing Notice
3 June 2026Change of Director's Interest Notice
3 June 2026Application for quotation of securities - ADO
1 June 2026Cleansing Notice
1 June 2026Application for quotation of securities - ADO
29 May 2026Proposed issue of securities - ADO

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.